Illuminating oral health: AIEgens for phototheranostics DOI Creative Commons
Jingyuan Chen, Wenhao Yan, Xinyu Wang

et al.

Published: March 1, 2025

Language: Английский

Near‐Infrared Light‐Driving Organic Photothermal Agents with an 88.9% Photothermal Conversion Efficiency for Image‐Guided Synergistic Phototherapy DOI
Xilin Zhao, Mengxin Sun,

Cao Xiaohan

et al.

Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: 13(19)

Published: March 23, 2024

Photothermal agents (PTAs) with desirable near-infrared (NIR) absorption and excellent photothermal conversion efficiency (PCE) are ideal candidates for cancer treatment. However, numerous PTAs still require high-intensity long-duration laser irradiation to completely ablate the tumor during therapy (PTT) process, resulting in light damage healthy skin tissue as well limiting their biomedical applications. Integrating intense NIR high PCE into a single small-molecule PTA is an important prerequisite realizing efficient PTT, but serious challenge. Herein, series of donor-acceptor type (CC1 NC4) designed through molecular engineering strategy. Theoretical calculations experimental results show that effect from CC1 NC4 significantly enhanced expected. Notably, nanoparticles exhibit absorption, superhigh up 88.9% photoacoustic imaging imaging, effective reactive oxygen species generation photodynamic (PDT). The superior PTT/PDT synergistic phototherapeutic efficacy demonstrated by complete elimination vivo upon one-time, low-intensity, short-duration (808 nm, 330 mW cm

Language: Английский

Citations

7

Albumin-Energized NIR-II Cyanine Dye for Fluorescence/Photoacoustic/Photothermal Multi-Modality Imaging-Guided Tumor Homologous Targeting Photothermal Therapy DOI
Shanshan Jiang, Wanyu Li,

Benhao Li

et al.

Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 29, 2025

Endowing cyanine dyes with hydrophilicity, long blood circulation, tumor targeting, and robust therapeutic efficacy in the second near-infrared (NIR-II) window is challenging for cancer treatment. Herein, we develop cell membrane-coated albumin-NIR-II dye assemblies, denoted as LZ-1105@HAm, to optimize photophysical properties of aqueous solution NIR-II fluorescence (FL)/photoacoustic (PA)/photothermal (PT) multimodality imaging-guided homologous targeting photothermal therapy. LZ-1105@HAm exhibits good extends half-life circulation from 0.634 ± 0.058 1.919 0.107 h, enhances FL/PA/PT imaging capabilities vitro vivo, improves conversion efficiency 34.6% 45.4%. Additionally, membrane coating confers assemblies tumor-specific capability, increasing accumulation enabling efficient ablation. Upon 1064 nm laser irradiation, demonstrates significantly improved efficacy. This research provides a strategy constructing dye-based nanotheranostics potential clinical application prospects.

Language: Английский

Citations

1

Engineered Cell Membrane Coating Technologies for Biomedical Applications: From Nanoscale to Macroscale DOI
Yongqi An, Cheng Ji, Hao Zhang

et al.

ACS Nano, Journal Year: 2025, Volume and Issue: unknown

Published: March 24, 2025

Cell membrane coating has emerged as a promising strategy for the surface modification of biomaterials with biological membranes, serving cloak that can carry more functions. The cloaked inherit diverse intrinsic biofunctions derived from different cell sources, including enhanced biocompatibility, immunity evasion, specific targeting capacity, and immune regulation regenerative microenvironment. characteristics biomimicry biointerfacing have demonstrated versatility technology on variety biomaterials, thus, furthering research into wide range biomedical applications clinical translation. Here, preparation coatings is emphasized, sizes coated nanoscale to macroscale well engineering strategies introduce additional are summarized. Subsequently, utilization biomimetic membrane-cloaked in discussed, drug delivery, imaging phototherapy, cancer immunotherapy, anti-infection detoxification, implant modification. In conclusion, latest advancements preclinical studies, along multiple benefits membrane-coated nanoparticles (NPs) systems, elucidated.

Language: Английский

Citations

1

BODIPY-Based Photothermal Agent Incorporating Azulene for Enhanced NIR Absorption and Tumor Ablation DOI
Kai Nishimura,

Mikiya Kato,

Tomoya Fukui

et al.

Molecular Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Photothermal therapy (PTT) is a promising minimally invasive treatment that converts light energy into localized heat for tumor ablation. Indocyanine green (ICG), the only clinically approved photothermal agent (PTA), suffers from rapid photobleaching and poor retention, underscoring urgent need next-generation PTAs with improved properties. In this study, we report AzuGlu-BODIPY, novel azulene-containing BODIPY-based PTA incorporating 1,2,3,4-tetrahydroquinoline glucose, designed to overcome these limitations. AzuGlu-BODIPY demonstrates high conversion efficiency (PCE) of 51%, effective near-infrared (NIR) absorption, thermal stability in both dimethyl sulfoxide (DMSO) aqueous solutions. vitro studies revealed potent efficacy against cancer cell lines, IC50 values 3.1–4.6 μM under 808 nm laser irradiation, while vivo experiments showed complete regression 4T1 tumor-bearing mice following administration treatment. These results suggest as provide versatile platform advancing azulene-based enhanced functionality PTT.

Language: Английский

Citations

1

A thermoresponsive nanocomposite integrates NIR-II-absorbing small molecule with lonidamine for pyroptosis-promoted synergistic immunotherapy DOI Creative Commons
Pengfei Chen, Chi Zhang,

Liuliang He

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: April 10, 2024

Photothermal immunotherapy is regarded as the ideal cancer therapeutic modality to against malignant solid tumors; however, its benefits are often modest and require improvement. In this study, a thermoresponsive nanoparticle (BTN@LND) composed of photothermal agent (PTA) pyroptosis inducer (lonidamine) were developed enhance applications. Specifically, our "two-step" donor engineering strategy produced strong NIR-II-absorbing organic small-molecule PTA (BTN) that exhibited high NIR-II performance (ε

Language: Английский

Citations

5

Recent advances in biomaterials based near-infrared mild photothermal therapy for biomedical application: A review DOI
Yu Cai,

Zhenye Lv,

Xiaoyi Chen

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 278, P. 134746 - 134746

Published: Aug. 13, 2024

Language: Английский

Citations

4

Novel NIR-II 3,5-Julolidinyl aza-BODIPY for Photothermal Therapy of Gliomas Stem Cells by Brain Stereotactic Injection DOI

Lulu Cao,

Zhiqiang Cui, Dongxiang Zhang

et al.

ACS Materials Letters, Journal Year: 2024, Volume and Issue: 6(10), P. 4765 - 4773

Published: Sept. 20, 2024

Language: Английский

Citations

4

Nano‐Armed Limosilactobacillus reuteri for Enhanced Photo‐Immunotherapy and Microbiota Tryptophan Metabolism against Colorectal Cancer DOI Creative Commons
Haiting Xu, Yajun Wang,

Ga Liu

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 30, 2024

Despite being a groundbreaking approach to treating colorectal cancer (CRC), the efficacy of immunotherapy is significantly compromised by immunosuppressive tumor microenvironment and dysbiotic intestinal microbiota. Here, leveraging superior carrying capacity innate immunity-stimulating property living bacteria, nanomedicine-engineered bacterium, LR-S-CD/CpG@LNP, with optical responsiveness, immune-stimulating activity, ability regulate microbiota metabolome developed. Immunoadjuvant (CpG) carbon dot (CD) co-loaded plant lipid nanoparticles (CD/CpG@LNPs) are constructed conjugated surface Limosilactobacillus reuteri (LR) via reactive oxygen species (ROS)-responsive linkers. The inherent photothermal photodynamic properties oral CD/CpG@LNPs induce in situ cytotoxic ROS generation immunogenic cell death cells. generated neoantigens released CpG function as potent vaccine that stimulates maturation immature dendritic mature cells metabolites secreted LR subsequently facilitated infiltration T lymphocytes eradicate tumors. further vivo results demonstrate photo-immunotherapy microbial metabolite regulation LR-S-CD/CpG@LNPs collectively suppressed growth orthotopic tumors their liver metastases, presenting promising avenue for synergistic treatment CRC route.

Language: Английский

Citations

4

Self-assembled co-delivery system of gold nanoparticles and paclitaxel based on in-situ dynamic covalent chemistry for synergistic chemo-photothermal therapy DOI
Xiaoxia Wu,

Dinghu Zhang,

Yinan Ding

et al.

Rare Metals, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 6, 2024

Language: Английский

Citations

3

Biomimetic celastrol nanocrystals with enhanced efficacy and reduced toxicity for suppressing breast cancer invasion and metastasis DOI

Shuang Du,

Kui Wu,

Yucheng Guan

et al.

International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: 671, P. 125221 - 125221

Published: Jan. 19, 2025

Language: Английский

Citations

0